Heidelberg Pharma AG

Director's Dealing • Feb 9, 2012

News Details

Directors’ Dealings | 9 February 2012 19:08

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Wilhelm First name: Prof. Olaf G. Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: Bearer shares of common stock ISIN/WKN of the financial instrument: DE000A1MMAS8 Type of transaction: Subscription/Purchase Date: 06.02.2012 Price: 3.10 Currency: EUR No. of items: 4000 Total amount traded: 12400.00 Place: Ausserbörslich / OTC Explanation for publication: Subscription of the new shares(DE000A1MMAS8) using subscription rights from the rights issue of WILEX AG (DE0006614720), which was registered in the Commercial Register on 03.02.2012. Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 09.02.2012 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 14828